A Russian company is preparing to launch clinical trials of a peptide vaccine against cancer in 2027
⚡ Quick Summary
The Russian pharmaceutical company Promomed announced its plans to begin in 2027 the first phase of clinical trials for a new peptide anti-cancer vaccine.
📰 Related Articles
Truce: Sonelgaz enhances its capabilities in preparation for the summer and electricity production exceeds 27 thousand megawatts in Algeria
النهار DZ
The astronomical prices of seasonal fruits draw Al-Bawari to parliamentary accountability
آشكاين
Marrakesh hosts the fourth session of the Euro-Mediterranean and Gulf Parliamentary Economic Forum
اليوم 24
Russian Embassy: There are no Russian citizens on board the detained tanker Smyrtos
RT عربي
فوكس تتقدم بعرض نقدي وأسهم بـ19،1 مليار يورو لشراء منصة روكو للبث
Euronews عربي